These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 6212068)

  • 61. Relationship between regression of cardiovascular hypertrophy and rate of redevelopment of hypertension.
    Korner PI; Jennings GL; Esler MD
    J Clin Hypertens; 1987 Sep; 3(3):341-8. PubMed ID: 2959758
    [No Abstract]   [Full Text] [Related]  

  • 62. Importance of blood pressure variability in organ protection in spontaneously hypertensive rats treated with combination of nitrendipine and atenolol.
    Xie HH; Miao CY; Liu JG; Su DF
    Acta Pharmacol Sin; 2002 Dec; 23(12):1199-204. PubMed ID: 12466061
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Course of hypertension and the potentials for regression].
    Shkhvatsabaia IK
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1982; 5(1):5-12. PubMed ID: 6212068
    [No Abstract]   [Full Text] [Related]  

  • 64. [Calcium antagonists].
    Littler WA
    Cardiologia; 1984; 29(1-2):121-7. PubMed ID: 6398704
    [No Abstract]   [Full Text] [Related]  

  • 65. Effects of antihypertensive treatment on vascular remodeling in essential hypertensive patients.
    Schiffrin EL; Deng LY; Larochelle P
    J Cardiovasc Pharmacol; 1994; 24 Suppl 3():S51-6. PubMed ID: 7700067
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cerebral blood flow autoregulation in hypertension and effects of antihypertensive drugs.
    Barry DI; Lassen NA
    J Hypertens Suppl; 1984 Dec; 2(3):S519-26. PubMed ID: 6400382
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cardiac morphology and function in arterial hypertension. The effects of a new multifactorial hypotensive agent: urapidil.
    Ghione S; Genovesi-Ebert A; Marabotti C; Spinazzi A; Noseda A
    Blood Press Suppl; 1994; 4():25-30. PubMed ID: 7804509
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Resistant hypertension: Core Curriculum 2008.
    Parker MG
    Am J Kidney Dis; 2008 Oct; 52(4):796-802. PubMed ID: 18706748
    [No Abstract]   [Full Text] [Related]  

  • 69. [[Antihypertensive therapy and organ protection].
    Stella ML; Grassi G; Paleari F; Gamba P; Mancia G
    Cardiologia; 1996 May; 41 Suppl 1():19-23. PubMed ID: 8831177
    [No Abstract]   [Full Text] [Related]  

  • 70. Mechanism(s) of systolic blood pressure reduction and drug therapy in hypertension.
    Safar ME
    Hypertension; 2007 Jul; 50(1):167-71. PubMed ID: 17420338
    [No Abstract]   [Full Text] [Related]  

  • 71. [Diagnostic and therapeutic problems in hypertensive heart disease].
    Strauer BE
    Z Kardiol; 1993; 82 Suppl 4():17-24. PubMed ID: 8147058
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
    Palmieri V; Devereux RB
    Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Early structural changes in hypertension: pathophysiology and clinical consequences.
    Folkow B
    J Cardiovasc Pharmacol; 1993; 22 Suppl 1():S1-6. PubMed ID: 7507535
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [The heart and arterial hypertension].
    Shkhvatsabaia IK
    Kardiologiia; 1982 Mar; 22(3):5-13. PubMed ID: 6210793
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.